DE3772687D1 - Arzneimittel zur heilung von arteriosklerose, enthaltend ein pyrimido(2,1-b)benzothiazol-derivat. - Google Patents

Arzneimittel zur heilung von arteriosklerose, enthaltend ein pyrimido(2,1-b)benzothiazol-derivat.

Info

Publication number
DE3772687D1
DE3772687D1 DE8787112499T DE3772687T DE3772687D1 DE 3772687 D1 DE3772687 D1 DE 3772687D1 DE 8787112499 T DE8787112499 T DE 8787112499T DE 3772687 T DE3772687 T DE 3772687T DE 3772687 D1 DE3772687 D1 DE 3772687D1
Authority
DE
Germany
Prior art keywords
pyrimido
medicines
healing
benzothiazole derivative
arteriosclerosis containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787112499T
Other languages
English (en)
Inventor
Ryuji Niwa
Nobuya Katagiri
Tetsuzu Kato
Yoshiyasu Shitori
Jiro Horiuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KANTO ISHI PHARMA CO Ltd
Mect Corp
Original Assignee
KANTO ISHI PHARMA CO Ltd
Mect Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61202357A external-priority patent/JPS6357522A/ja
Priority claimed from JP62187383A external-priority patent/JPS6431720A/ja
Application filed by KANTO ISHI PHARMA CO Ltd, Mect Corp filed Critical KANTO ISHI PHARMA CO Ltd
Application granted granted Critical
Publication of DE3772687D1 publication Critical patent/DE3772687D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8787112499T 1986-08-28 1987-08-27 Arzneimittel zur heilung von arteriosklerose, enthaltend ein pyrimido(2,1-b)benzothiazol-derivat. Expired - Fee Related DE3772687D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61202357A JPS6357522A (ja) 1986-08-28 1986-08-28 ピリミド〔２，１−ｄ〕ベンゾチアゾ−ル誘導体からなる血小板凝集抑制剤
JP62187383A JPS6431720A (en) 1987-07-27 1987-07-27 Antihyperlipemic agent consisting of pyrimido(2,1-b)benzothiazole derivative

Publications (1)

Publication Number Publication Date
DE3772687D1 true DE3772687D1 (de) 1991-10-10

Family

ID=26504322

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787112499T Expired - Fee Related DE3772687D1 (de) 1986-08-28 1987-08-27 Arzneimittel zur heilung von arteriosklerose, enthaltend ein pyrimido(2,1-b)benzothiazol-derivat.

Country Status (9)

Country Link
EP (1) EP0261439B1 (de)
KR (1) KR900000293B1 (de)
CN (1) CN1016668B (de)
AT (1) ATE66812T1 (de)
AU (1) AU591419B2 (de)
CA (1) CA1297100C (de)
DE (1) DE3772687D1 (de)
DK (1) DK453387A (de)
NZ (1) NZ221579A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839839A1 (de) * 1988-11-25 1990-05-31 Henning Berlin Gmbh Mittel zur behandlung von chronisch entzuendlichen darmerkrankungen
US5484605A (en) * 1988-11-25 1996-01-16 Henning Berlin Gmbh Chemie-Und Pharmawerk Agent for treating chronically inflammatory intestinal diseases
DE4444930A1 (de) * 1994-12-16 1996-06-27 Cassella Ag 2-Amino-1,3-thiazepine und deren Verwendung als Hemmstoffe der Stickstoffmonoxid-Synthase
AU2404897A (en) 1996-04-24 1997-11-12 Takeda Chemical Industries Ltd. Fused imidazopyridine derivatives as antihyperlipidemic agents
US5693641A (en) * 1996-08-16 1997-12-02 Berlex Laboratories Inc. Bicyclic pyrimidine derivatives and their use as anti-coagulants

Also Published As

Publication number Publication date
DK453387A (da) 1988-02-29
AU591419B2 (en) 1989-11-30
NZ221579A (en) 1990-04-26
ATE66812T1 (de) 1991-09-15
EP0261439A2 (de) 1988-03-30
KR900000293B1 (ko) 1990-01-25
EP0261439B1 (de) 1991-09-04
CN87105862A (zh) 1988-03-16
KR890003372A (ko) 1989-04-14
CA1297100C (en) 1992-03-10
AU7743187A (en) 1988-03-03
CN1016668B (zh) 1992-05-20
DK453387D0 (da) 1987-08-28
EP0261439A3 (en) 1990-01-24

Similar Documents

Publication Publication Date Title
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
NO901372D0 (no) Framgangsmaate for tilvirking av medikament-baerer.
ATE169616T1 (de) Zwischenverbindungen zur herstellung von fungiziden
NO882123D0 (no) Maskering for antibiotikum.
NO874347D0 (no) Fremgangsmaate for fremstilling av insulin.
DE3779053D1 (de)
NO890970L (no) Fremgangsmaate for fremstilling av cykliske sulfater.
NO890540D0 (no) Fremgangsmaate for fremstilling av et proteinholdig naeringsmiddel.
DE68912160D1 (de) Verfahren zur Herstellung von beta-Lactamderivaten.
NO904513L (no) Fremgangsmaate for fremstilling av et naeringsmiddel.
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
DE3772687D1 (de) Arzneimittel zur heilung von arteriosklerose, enthaltend ein pyrimido(2,1-b)benzothiazol-derivat.
NO903303L (no) Fremgangsmaate for alfa-hydroksyketoner.
FI873429A (fi) Oftalmologiska kompositioner foer behandling av nervdegenerationer.
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
FI883759A (fi) C.12-modifierade etromycin a-derivat.
DK591787D0 (da) Anvendelse af 5-(substitueret phenyl)-oxa-zolidinonderivater til fremstilling af et til behandling af depressioner egnet laegemiddel
AU639322B2 (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
EP0235904A3 (de) Behandlung von Allergie mit Thymopentin
CS318690A3 (en) Pharmaceutical composition usable for depression therapy
DE68913801T2 (de) Verfahren zur Herstellung von auf 5-C-Hydroxymethylaldohexose basierende Verbindungen.
DE68919887T2 (de) Verfahren zur Herstellung von 1-alpha,25-dihydroxy-vitamin D2 und dessen 24-Epimer.
NO882257D0 (no) Fremgangsmaate for fremstilling av et glidelaasbaand.
FI890065A (fi) Foerfarande foer framstaellning av 5,8,13, 14-tetrahydrobenz/5,6/isoindolo/2,1-b/isokinolin-8,13-dionderivat.
ATE75613T1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee